MASCC/ISOO Clinical Practice Statement: Management of oral manifestations of chronic graft-versus-host-disease
Authors:
Open Access
- 25 July 2024
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (8) , 1-6
Abstract
Purpose: A MASCC/ISOO Clinical Practice Statement (CPS) is aimed at generating a concise tool for clinicians, which concentrates practical information needed for the management of oral complications of cancer patients. This CPS is focused on the management of oral manifestations of chronic graft-versus-host-disease (cGVHD). Methods: This CPS was developed based on critical evaluation of the literature followed by a structured discussion of a group of leading experts, members of the Oral Care Study Group of MASCC/ISOO. The information is presented in the form of succinct bullets and table to generate a short manual about the best standard of care. Results: The treatment goals in oral cGVHD are to relieve pain and xerostomia, improve oral function, prevent secondary infection, prevent deterioration of the dentition, and detect malignant transformation as early as possible. The prevention and treatment measures for oral mucosal lesions, hypofunction of the salivary glands, and sclerodermatous changes in the oral and perioral tissues are detailed, as well as the possible complications and side effects of these interventions. Conclusions: Patients post allogeneic hematopoietic cell transplantations, with cGVHD manifest in the oral and perioral tissues, should be regularly monitored and treated as needed by an oral care practitioner. This CPS provides the clinician with practical tools for examining, preventing, and treating the various sequalae that may affect the oral cavity in these patients.Keywords
Funding Information
- Hebrew University of Jerusalem
This publication has 17 references indexed in Scilit:
- Use of Prescription Sialagogues for Management of Xerostomia in Chronic Graft-versus-Host-DiseaseTransplantation and Cellular Therapy, 2021
- Photobiomodulation (low-level laser) therapy for immediate pain relief of persistent oral ulcers in chronic graft-versus-host diseaseSupportive Care in Cancer, 2021
- Oral chronic graft-versus-host diseaseThe Journal of the American Dental Association, 2020
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapyCancer, 2020
- Evidence-based clinical practice guideline on nonrestorative treatments for carious lesionsThe Journal of the American Dental Association, 2018
- Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective studyInternational Journal of Hematology, 2018
- Economic and Practical Considerations in the Treatment of Oral Mucosal Chronic Graft-Versus-Host DiseaseTransplantation and Cellular Therapy, 2018
- Photobiomodulation therapy in the management of chronic oral graft-versus-host diseaseSupportive Care in Cancer, 2016
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group ReportTransplantation and Cellular Therapy, 2015
- Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)Supportive Care in Cancer, 2014